Evidentiary Significance of Routine EEG in Refractory Cases: A Paradigm Shift in Psychiatry

Area of Science:

• Neuroscience
• Psychiatry
• Medical Diagnostics

Background:

• Current psychiatric medication prescribing relies on symptom presentation, leading to challenges and high failure rates.
• A paradigm shift toward precision medicine is advocated by major institutions like the National Institute of Mental Health and the World Psychiatric Association.
• This study addresses the need for objective biomarkers to guide psychiatric treatment.

Purpose of the Study:

• To identify objective biomarkers for psychiatric medication failure.
• To provide evidence supporting a move towards precision medicine in psychiatry.
• To explore the utility of electroencephalograms (EEGs) in identifying treatment-resistant psychiatric conditions.

Main Methods:

• Collected and analyzed electroencephalograms (EEGs) from 1,233 psychiatric patients starting in 2012.
• Utilized a single, board-certified neurophysiologist for consistent EEG analysis.
• Identified specific EEG patterns indicative of brain dysregulation.

Main Results:

• Identified 4 key EEG biomarkers associated with psychiatric medication failure: focal slowing, spindling excessive beta, encephalopathy, and isolated epileptiform discharges.
• These EEG biomarkers indicate underlying brain dysregulation not detectable through standard psychiatric assessments.
• The identified biomarkers can manifest as complex behavioral or psychiatric symptoms, complicating diagnosis.

Conclusions:

• The identified EEG biomarkers offer a novel approach to understanding psychiatric medication failure.
• This biomarker-based approach represents a significant step towards personalized medicine in psychiatry.
• The findings encourage a shift towards objective biological testing of the brain in psychiatric practice.